Navigation Links
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
Date:12/15/2009

rward-looking statements and related assumptions.

Such factors include (but are not limited to) the following:

  1. the ability to continue as a going concern;
  2. the consent decree between the Company and the U.S. Food and Drug Administration (the "FDA") and the Company's suspension of the production and shipment of all of the products that the Company manufactures and the related nationwide recall affecting all of the products that the Company manufactures, as well as the related material adverse effect on the Company's revenue, assets and liquidity and capital resources, all as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8-K filed with the SEC on March 3, 2009, the Company's Form 8-K filed with the SEC on April 30, 2009, the Company's Form 8-K filed with the SEC on July 24, 2009 and the Company's Form 8-K filed with the SEC on November 12, 2009;
  3. the degree to which the findings of the Audit Committee inquiry referenced in the Company's Form 10-Q for the quarter ended June 30, 2008, the Company's Form 12b-25 filed with the SEC on November 13, 2008, the Company's Form 12b-25 filed with the SEC on February 2, 2009, the Company's Form 12b-25 filed with the SEC on June 6, 2009, the Company's Form 8-K filed with the SEC on June 23, 2009, the Company's two Form 12b-25s filed with the SEC on November 10, 2009, as well as certain other of the Company's SEC filings, could have a material impact on the Company's financial results;
  4. changes in the current and future business environment, including interest rates and capital and consumer spending;
  5. the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized;
  6. the possibility of not obtaining FDA approvals or delay in obtaining FDA approvals;
  7. acceptance of and demand for the Company's ne
    '/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
2. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
3. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
4. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
5. New Report Grades Sustainability Reporting of Top Pharmaceutical Companies
6. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
9. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
10. New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
11. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 Quantum Materials Corp (OTCQB:QTMM) today ... photoactive quantum dots for use in next-generation ... advantages for solar power generation, the high cost ... dots with which to develop thin film solar ... utilization and acceptance. The company is also seeking ...
(Date:10/1/2014)... Oct. 1, 2014 Ardelyx, Inc. ... biopharmaceutical company focused on cardio-renal, gastrointestinal and ... its 371 patient Phase 2b clinical trial ... bowel syndrome (IBS-C).  Results from this study ... in IBS-C symptoms for tenapanor-treated patients compared ...
(Date:10/1/2014)... , October 1, 2014 ... Next Generation Sequencing (NGS) data analysis, today launches a ... cystic fibrosis analysis in a single NGS experiment. The ... all types of variants in a single NGS experiment ... it has not been possible to simultaneously analyse all ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... ST. LOUIS, April 21, 2011 / PRNewswire/ ... FDA approved liquid potassium iodide product indicated for thyroid ... has implemented the changes necessary to ramp up production ... ThyroShield is an over-the-counter iodide solution which, ...
... Ind., April 21, 2011 Hill-Rom Holdings, Inc., (NYSE: ... a management presentation at Deutsche Bank,s 36th Annual Health ... 2:10 p.m. ET. You are invited to ... at http://ir.hill-rom.com/events.cfm or access it directly at ...
Cached Medicine Technology:Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
(Date:10/1/2014)... 2014 Lifeinsurance-policy.com has released a ... life insurance prices for smokers. , Smoking will always ... Comparing quotes is the best method to find affordable ... customers who need coverage. , Whole life insurance ... the policy. Since the coverage is permanent, the initial ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... October 01, 2014 Between 23 million ... the U.S., according to figures from the National Institutes ... Association (AARDA), and many of them have something else ... having undiagnosed celiac disease. Gluten Free Therapeutics, makers ... of undiagnosed celiac disease by publishing a series of ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... 35% More Weight and Have Better Quality of,Life, ... GAINESVILLE, Fla., Oct. 28 Those patients who ... 35,percent more weight the first year and tend to ... new patient and bariatric surgeon surveys,conducted by Harris Interactive(R), ...
... protect all, studies show shots cut deaths, hospital visits ... people who get the flu vaccine, the better it ... In the first study, researchers from the Institute for ... a universal vaccination program implemented in the Ontario province ...
... Also Underscores High Level of Patient Dissatisfaction with ... am PDT -- UCB announced,today findings from large-scale ... that showed patients rating themselves,as having substantially less ... believed. The survey also showed disagreement between,physicians and ...
... Cardiogenesis,Corporation (Pink Sheets: CGCP), announced that the company ... 30, 2008 prior to market open,on Thursday, November ... P. Lanigan and Senior Vice President and Chief ... conference call that day at 12:00,p.m. Eastern time ...
... Oct. 28 Pharmasset, Inc.,(Nasdaq: VRUS ) today ... American Association for the Study of Liver Diseases (AASLD) ... During this webcast, management,will review Pharmasset,s progress on the ... To access a simultaneous webcast of this event ...
... IOP of 20% from baseline at 12 weeks ... QLTI;,TSX: QLT) ("QLT" or the "Company") today announced data ... by QLT,s wholly-owned subsidiary,QLT Plug Delivery, Inc. (QPD), to ... Delivery System (L-PPDS) for the treatment of open,angle glaucoma ...
Cached Medicine News:Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 2Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 3Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 4Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 5Health News:When It Comes to Flu, the More Who Get Vaccine, the Better 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 3Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 4Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 5Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 2Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 3Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 2Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 3Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 4Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 5Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 6
... Trocar is a full-featured trocar that consists of ... shield. The shield is designed to cover the ... puncture or laceration once the abdominal or thoracic ... option is designed to enhance trocar sleeve fixation ...
... trocar that consists of a sharp pyramidal blade, ... cover the pyramidal tip to protect internal structures ... thoracic cavity has been entered. Due to reduced ... not required. , ,The single-patient use trocar ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: